|
FAM3C expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62458935193399E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.72417635724287E-13 |
| Normal-vs-Stage2 |
1.635220E-03 |
| Normal-vs-Stage3 |
1.10249587237377E-11 |
| Normal-vs-Stage4 |
4.07089999999721E-05 |
| Stage1-vs-Stage2 |
3.258400E-01 |
| Stage1-vs-Stage3 |
1.818630E-01 |
| Stage1-vs-Stage4 |
5.262600E-01 |
| Stage2-vs-Stage3 |
7.933800E-02 |
| Stage2-vs-Stage4 |
2.350600E-01 |
| Stage3-vs-Stage4 |
8.290200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.11022302462516E-14 |
| Normal-vs-AfricanAmerican |
2.424800E-04 |
| Normal-vs-Asian |
3.62540000020672E-07 |
| Caucasian-vs-AfricanAmerican |
6.324400E-01 |
| Caucasian-vs-Asian |
9.784400E-01 |
| AfricanAmerican-vs-Asian |
6.181800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.57929999978057E-07 |
| Normal-vs-Female |
<1E-12 |
| Male-vs-Female |
8.571600E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.18887147191072E-12 |
| Normal-vs-Age(41-60Yrs) |
3.7336800318144E-13 |
| Normal-vs-Age(61-80Yrs) |
9.30559999945402E-07 |
| Normal-vs-Age(81-100Yrs) |
1.192250E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.514000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.203400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.973600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.672200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.060600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.647800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
5.843600E-02 |
| Classical-VS-Follicular |
4.152200E-04 |
| Classical-VS-Other |
1.591380E-01 |
| Classical-VS-Normal |
<1E-12 |
| Tall-VS-Follicular |
1.183930E-04 |
| Tall-VS-Other |
1.957750E-02 |
| Tall-VS-Normal |
7.17680004314047E-09 |
| Follicular-VS-Other |
8.138600E-01 |
| Follicular-VS-Normal |
2.303800E-03 |
| Other-VS-Normal |
4.421600E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.00069996733509E-09 |
| Normal-vs-N1 |
3.90180000000573E-05 |
| N0-vs-N1 |
2.050000E-01 |
|
|
